Our study found that CAD patients have a high expression of S100A8, which supports the view that a chronic inflammatory response occurs in CAD; therefore, this model may provide a new therapeutic target for the diagnosis and treatment of CAD. Here, S100A8 is linked to coronary artery disorder.